Circulating tumour DNA (ctDNA) as a biomarker in metachronous melanoma and colorectal cancer- a case report

BACKGROUND: Circulating tumour DNA (ctDNA) has emerged as a promising blood-based biomarker for monitoring disease status of patients with advanced cancers. The presence of ctDNA in the blood is a result of biological processes, namely tumour cell apoptosis and/or necrosis, and can be used to monito...

Descripción completa

Detalles Bibliográficos
Autores principales: Calapre, Leslie, Warburton, Lydia, Millward, Michael, Gray, Elin S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857141/
https://www.ncbi.nlm.nih.gov/pubmed/31727009
http://dx.doi.org/10.1186/s12885-019-6336-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857141/
https://www.ncbi.nlm.nih.gov/pubmed/31727009
http://dx.doi.org/10.1186/s12885-019-6336-3

Ejemplares similares